The protein kinase C (PKC) family consists of multiple subspecies that possess a conserved catalytic domain. The classic or group A isoforms (α, β, and γ) require Ca^2+^ for activity and contain cysteine-rich motifs that confer phospholipid-dependent binding of diacylglycerol ([@B1]). The group A PKCs are cleaved at the third variable region (V~3~) by the neutral proteases, calpains I and II, to catalytically active fragments ([@B2]). Recent studies have demonstrated that the Ca^2+^-independent δ isoform, and not the group A PKCs, is selectively cleaved at V~3~ to a catalytically active fragment in cells induced to undergo apoptosis ([@B3], [@B4]). Inhibition of apoptosis by overexpression of Bcl-2 or Bcl-x~L~ is associated with a block of PKCδ cleavage ([@B3], [@B4]). The finding that PKCδ is cleaved at a site (DMQD/N) adjacent to aspartic acid has supported the potential involvement of aspartate-specific cysteine proteases which are known to be activated during apoptosis.

The nematode Ced-3 cysteine protease is related to the mammalian interleukin-1β converting enzyme (ICE) ([@B5], [@B6]). The demonstration that overexpression of Ced-3 or ICE induces apoptosis has provided support for involvement of these cysteine proteases in cell death pathways ([@B7]). ICE/ Ced-3 family members include Nedd2/Ich-1, CPP32/ YAMA/apopain, Tx/Ich-2/ICE~rel~II, ICE~rel~III, Mch2, Mch3/ ICE-LAP3/CMH-1 (reviewed in reference [@B8]), ICE-LAP6 ([@B9]), FLICE/Mch5 ([@B10], [@B11]), and Mch4 ([@B11]). ICE cleaves the precursor of IL-1β to the active cytokine ([@B6], [@B12], [@B13]). Other known substrates of the ICE/Ced-3 family include: (*a*) poly (ADP-ribose) polymerase (PARP) which is cleaved by CPP32, Mch3 and Ced-3, but not ICE ([@B14]--[@B16]); and (*b*) DNA-dependent protein kinase (DNA-PK), the U1 small nuclear ribonucleoprotein and D4-GDP dissociation inhibitor for the Rho family GTPases (D4-GDI), which are cleaved by CPP32 ([@B17], [@B18]). However, the functional role of these cleavage products in the induction of apoptosis is unclear.

The present results demonstrate that PKCδ is cleaved by CPP32 and not certain other ICE/Ced-3 family members. We also demonstrate that overexpression of the PKCδ catalytic fragment is involved in the induction of phenotypic changes that are characteristic of apoptosis.

Materials and Methods
=====================

In Vitro Cleavage of PKCδ and PARP.
-----------------------------------

The full-length PKCδ cDNA was cloned into the SpeI and BamH1 sites of a modified pSVβ plasmid (Clontech, Palo Alto, CA). PKCδ(D327A/D330A) was generated in two steps by overlapping primer extension. PARP cDNA was generated by PCR cloning. The proteins were labeled with \[^35^S\]methionine by coupled transcription and translation reactions (Promega, Madison, WI). Labeled proteins were incubated with 5 μg/ml *Escherichia coli*-derived CPP32β in 50 mM Hepes (pH 7.5), 10% glycerol, 2.5 mM DTT, and 0.25 mM EDTA at room temperature for 30 min. The reaction products were analyzed by electrophoresis in 10-20% SDS--polyacrylamide gels and then autoradiography. For the kinase assays, full-length PKCδ, PKCδ(D327A/D330A), PKCδ catalytic fragment (CF), and PKCδCF(K-R) were prepared by coupled transcription and translation. PKCδ and PKCδ(D327A/D330A) were incubated with 5 μg/ml CPP32β at room temperature for 30 min. Protein kinase assays using MBP as a substrate were performed as described (PKC Assay Kit; GIBCO BRL, Gaithersburg, MD).

Analysis of Peptide Proteolysis.
--------------------------------

Peptides were synthesized and purified to ∼95% by standard methods and confirmed by mass spectrometry. Reaction mixtures (810 μl) contained: 100 mM Hepes (pH 7.5), 20% (vol/vol) glycerol, 5 μM dithiothreitol, 0.5 mM EDTA, and 380 ng *N*-His CPP32 ([@B19]). Peptide substrates were added to final concentrations of 10 μM. The reaction mixtures were incubated at 30°C. Aliquots were removed at 10 min intervals for 60 min and added to vials containing 3 M HCl to stop the reactions. The amount of substrate remaining at each time was quantitated by reverse phase HPLC. Data were fit to the equation (S~t~/S~o~) = e^−kt^, where *k* is the decay rate constant equal to V~max~/K~m~. Observed V~max~/K~m~ values were normalized to 1.00 for the PARP peptide.

Cell Transfections.
-------------------

Cells were seeded at a density of 1.7 × 10^5^ in each well of 6-well dishes 24 h before transfection. For each well, 2 μg DNA construct and 0.5 μg pSvβ plasmid containing β-gal were coprecipitated with calcium phosphate. Cells were incubated with the coprecipitate for 30 h at 37°C and then analyzed by X-gal staining. Cells (1.7 × 10^5^/well) were also transfected with 2 μg DNA construct for 30 h at 37°C, fixed with 4% paraformaldehyde, postfixed with 5% acetic acid in ethanol and then stained with 5 μg/ml Hoechst dye. For sub-G1 DNA content, cells transfected by lipofectamine were stained with propidium iodide and monitored by FACScan^®^. Chromatin condensation was assessed by staining with acridine orange and ethidium bromide ([@B20]).

Results and Discussion
======================

To determine whether PKCδ is cleaved by one of the known ICE-like proteases, full-length 78-kD PKCδ labeled with \[^35^S\]methionine was incubated with purified recombinant proteases. Cleavage of PKCδ to a 40-kD fragment was observed with purified CPP32β ([@B14]) (Fig. [1](#F1){ref-type="fig"} *A*). In contrast, ICE failed to cleave PKCδ at concentrations up to 600 U/μl ([@B3]). The related Ich-1, Ich-2, Mch2, Mch3, and ICE~rel~III proteases also failed to cleave PKCδ (data not shown). Because PKCδ is cleaved at DMQD~330~N in vivo ([@B3], [@B4]), we asked whether this site is responsible for CPP32mediated cleavage in vitro. CPP32 may prefer peptidic substrates with aspartic acid at the P1 and P4 positions ([@B15]). Consequently, we prepared a PKCδ mutant with substitution of D327A and D330A. Incubation with CPP32 resulted in no detectable CPP32-mediated cleavage of this mutant to the 40-kD catalytic fragment, while there was partial digestion to a species of ∼55 kD (not observed with wild-type substrate) (Fig. [1](#F1){ref-type="fig"} *A*). Recombinant CPP32 also cleaved the 116-kD full-length PARP to the predicted 85-kD fragment ([@B14], [@B15]) (Fig. [1](#F1){ref-type="fig"} *A*). Using peptides derived from the cleavage sites of PARP and PKCδ in proteolytic assays, we found that CPP32 cleaves both substrates and not a peptide spanning the IL-1β maturation site (Table [1](#T1){ref-type="table"}). These findings confirm that PKCδ, like PARP, is a substrate for CPP32.

We also asked whether cleavage of PKCδ by CPP32 is associated with activation of the kinase function. Fulllength PKCδ exhibited a low level of myelin basic protein (MBP) phosphorylation, while incubation with CPP32 resulted in a greater than sixfold increase in kinase activity (Fig. [1](#F1){ref-type="fig"} *B*). In contrast, CPP32 had no detectable effect on kinase function of the PKCδ(D327A/D330A) mutant (Fig. [1](#F1){ref-type="fig"} *B*). A recombinant 40-kD CF of PKCδ (amino acids 331676) exhibited constitutive kinase activity, while a mutant of the fragment with K-378 in the ATP binding site mutated to R (K378R; designated K-R) yielded background levels of MBP phosphorylation found with control bacterial lysates (Figs. [1](#F1){ref-type="fig"}, *A* and *B*). These findings collectively demonstrate that CPP32-mediated cleavage of the DMQD~330~N site activates PKCδ.

To study the role of PKCδ in apoptosis, we used the transient HeLa cell transfection system previously found to demonstrate induction of apoptosis by ICE-like proteases ([@B7]). Cotransfection of the kinase inactive PKCδCF(K-R) mutant with the β-galactosidase (β-gal) marker gene had little effect on HeLa cell morphology (Fig. [2](#F2){ref-type="fig"} *A*). Most of the blue X-gal positive cells remained flat and attached to the dish (Fig. [2](#F2){ref-type="fig"} *A*). Cotransfection of the kinase active PKCδCF and β-gal resulted in condensed, small blue cells (Fig. [2](#F2){ref-type="fig"} *B*), consistent with the induction of apoptosis ([@B7]). Similar findings were obtained with NIH3T3 cells (Figs. [2](#F2){ref-type="fig"}, *C* and *D*). Overexpression of PKCδ in both cell types also resulted in detachment of non-viable cells into the culture medium.

Hoechst staining of HeLa cells transfected with a vector that expresses full-length PKCδ had no detectable changes in nuclear morphology (Fig. [3](#F3){ref-type="fig"} *A*), but overexpression of PKCδCF resulted in fragmented nuclei (Fig. [3](#F3){ref-type="fig"} *B*). Transfection of kinase inactive PKCδCF(K-R) was associated with a normal nuclear morphology (Fig. [3](#F3){ref-type="fig"} *C*). The changes observed with expression of the PKCδ CF were also compared to those found upon exposure to 1-β-[d]{.smallcaps}-arabinofuranosylcytosine (ara-C), a DNA-damaging agent that induces proteolytic cleavage of PKCδ and apoptosis ([@B4]). Treatment of HeLa cells with ara-C resulted in a similar pattern of nuclear fragmentation (Fig. [3](#F3){ref-type="fig"} *D*).

To confirm that the nuclear changes induced by PKCδCF are associated with induction of apoptosis, we assessed the effects of transfection on the appearance of HeLa cells with sub-G1 DNA content. Transfection of the empty vector, full-length PKCδ or PKCδCF(K-R) resulted in 10-15% of cells with sub-G1 DNA (Fig. [4](#F4){ref-type="fig"} *A* and data not shown). By contrast, transfection of PKCδCF was associated with 30-- 35% of cells with sub-G1 DNA (Fig. [4](#F4){ref-type="fig"} *A*). Cells were also stained with acridine orange and ethidium bromide to assess chromatin condensation ([@B20]). Transfection of PKCδCF, but not PKCδCF(K-R), resulted in the appearance of bright yellow-green nuclear staining of condensed chromatin (Fig. [4](#F4){ref-type="fig"} *B*).

To quantify the effects of PKCδCF expression on cell viability, we cotransfected PKCδCF or PKCδCF(K-R) and the green fluorescence gene (Clontech) into HeLa cells. Positive transfectants were selected by flow cytometry, reseeded in culture medium and assayed at 24 h for viability by trypan blue exclusion. Less than 5% of the PKCδCF transfectants were viable, while over 90% of the kinase inactive PKCδCF(K-R) transfectants were viable and attached to the dish. Viability of 90--95% was observed after transfection of the null vector and sorting. We conclude that the kinase active catalytic domain of PKCδ induces characteristics typical of cells undergoing apoptosis: (*a*) size reduction and round morphology; (*b*) nuclear fragmentation; (*c*) chromatin condensation; (*d*) sub-G1 DNA content; and (*e*) detachment and loss of viability.

Multiple events that lead to destruction of nuclear and cytoplasmic integrity are probably required for apoptosis. Activation of ICE-family proteases may be a central trigger, resulting in the cleavage of substrates such as PARP ([@B21]), lamin B1 ([@B22], [@B23]), topoisomerase 1 ([@B23]), D4-GDI ([@B18]), DNA-PK, and the U1 small nuclear ribonucleoprotein ([@B17]). PKCδ, but not PKCα, β, ε, or ζ, is also cleaved at the onset of apoptosis ([@B3], [@B4]). Little is known about the physiological function of PKCδ ([@B24], [@B25]). We demonstrate that PKCδ is cleaved by CPP32 and not other ICE/Ced-3 family members in vitro. The results also demonstrate that expression of the PKCδ catalytic fragment induces morphologic changes characteristic of apoptosis. We propose that the proteolytic cleavage of PKCδ is a key mediator of nuclear fragmentation and cell death, and not a bystander effect of protease activation. Moreover, the finding that proteolytic activation of PKCδ is blocked by Bcl-2 and Bcl-x~L~ suggests that these anti-apoptotic proteins act upstream to this event ([@B3]). Elucidation of the substrates phosphorylated as a consequence of PKCδ cleavage should provide insights into the pathways activated by the catalytic fragment.
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![PKCδ is proteolytically activated by CPP32 in vitro. (*A*) PKCδ (full-length: FL), PKCδ(D327A/D330A) and PARP were labeled with \[^35^S\]methionine and incubated with recombinant CPP32β. The reaction products were analyzed by SDS-PAGE and autoradiography. The kinase active PKCδ catalytic fragment (CF) and the kinase inactive PKCδCF(K-R) were labeled with \[^35^S\]methionine and analyzed under similar conditions. (*B*) Recombinant PKCδ and PKCδ (D327A/D330A) were incubated with CPP32 and then assayed for protein kinase activity using MBP as substrate.](JEM.ghayur1){#F1}

###### 

CPP32 Proteolysis of Peptides Spanning the PARP, PKCδ, and IL-1β Cleavage Sites

  Substrate      Sequence                          Relative V~max~/K~m~
  ----------- -- ------------------------------ -- ----------------------
  PARP           Ac-WGDEVD~216~-GVDEVW-NH~2~       1.00
  PKCδ           Ac-GEDMQD~330~NSGTYW-NH~2~        0.42
  IL-1β          Ac-NEAYVHD~116~APVRSLY-NH~2~      0.00

![Transfection of the PKCδ catalytic fragment (CF) induces morphologic changes characteristic of apoptosis. HeLa (*upper panels*) and NIH3T3 (*lower panels*) cells were cotransfected with pSvβ-β-gal and vectors expressing: (*A* and *C*) kinase inactive PKCδCF(K-R) and (*B* and *D*) kinase active PKCδCF. Transfection was determined by X-gal staining and apoptotic cells were identified by their condensed morphology.](JEM.ghayur2){#F2}

![Expression of PKCδCF results in nuclear fragmentation. HeLa cells were transfected with vectors that express: (*A*) full-length PKCδ; (*B*) kinase active PKCδCF; and (*C*) kinase inactive PKCδCF(K-R). (*D*) Cells were exposed to 2 μM ara-C. The cells were fixed with paraformaldehyde and then stained with Hoechst dye. Cotransfection of PKCδFL, PKCδCF and PKCδCF(K-R) with pSvβ-β-gal demonstrated transfection efficiencies of 50, 42, and 43%, respectively. Percentage of apoptotic cells for the PKCδFL, PKCδCF, and PKCδCF(K-R) transfected populations was 2, 26, and 4%, respectively. Bar, 15 μM.](JEM.ghayur3){#F3}

![Overexpression of PKCδCF induces sub-G1 DNA and chromatin condensation. (*A*) HeLa cells were transfected with PKCδFL, PKCδCF, or PKCδCF(K-R). Cells were assessed for DNA content by flow cytometry at 48 h after transfection. The small triangle denotes G~0~/G~1~ DNA. (*B*) HeLa cells transfected with PKCδCF(K-R) (*left*) and PKCδCF (*right*) were assessed for chromatin condensation after staining with acridine orange and ethidium bromide.](JEM.ghayur4){#F4}
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